Clinical Trials Browser

Peripheral Nervous System Diseases

NCT07484022 2026-06-03

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Phase 1 Recruiting

37 enrolled

Genitourinary

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

NCT06848348 2026-05-29

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Phase 2 Recruiting

240 enrolled

BreastGastrointestinal

Cancer Pain, Breast Neoplasms, Neoplasms, Neuralgia, Pain, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT07109817 2026-05-29

DETOXp

Phase 2 Recruiting

116 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05404230 2026-05-19

OxaNeuro

Phase NA Recruiting

120 enrolled

Gastrointestinal

Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT05104736 2026-05-12

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Phase 2 Recruiting

53 enrolled

Thoracic

Thymic epithelial tumor, Peripheral Nervous System Diseases, Thymoma, Thymus Neoplasms

NCT07501663 2026-04-14

Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study

Phase NA Recruiting

60 enrolled

Peripheral Nervous System Diseases

NCT05990426 2026-03-24

FAST

Phase NA Recruiting

30 enrolled

Gynecologic

Intermittent Fasting, Ovarian Neoplasms, Peripheral Nervous System Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT07150117 2026-03-12

CYCLE-CIPN

Phase NA Recruiting

30 enrolled

Motor Activity, Neoplasms, Peripheral Nervous System Diseases

NCT06657157 2026-02-24

P-EVOLUTION

Recruiting

80 enrolled

Genitourinary

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

NCT06807294 2026-01-29

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

Phase NA Recruiting

21 enrolled

Peripheral Nervous System Diseases

NCT06400849 2025-12-23

ARIANE

Phase NA Recruiting

60 enrolled

Peripheral Nervous System Diseases

NCT05582551 2025-12-22

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Phase NA Recruiting

146 enrolled

Neoplasms, Peripheral Nervous System Diseases, Hearing Loss

NCT07285356 2025-12-16

GLOX-PEN

Phase NA Recruiting

84 enrolled

Gastrointestinal

Colonic Neoplasms, Peripheral Nervous System Diseases, Sarcopenia

NCT07025005 2025-11-04

VRd MM Fibrate

Phase 4 Recruiting

44 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT07160270 2025-09-08

This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process

Recruiting

90 enrolled

Lymphoid

Waldenstrom Macroglobulinemia, Peripheral Nervous System Diseases

Clinical Trials

EX-CIPN

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

DETOXp

OxaNeuro

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study

FAST

CYCLE-CIPN

P-EVOLUTION

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

ARIANE

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

GLOX-PEN

VRd MM Fibrate

This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process